Sequence sPecific ELImination of shiga-Toxin E. Coli

Project description

A pioneering antibiotic against toxic bacteria enters clinical trials

Field of science

• /social sciences/economics and business/business and management/commerce
• /natural sciences/biological sciences/genetics and heredity/mutation
• /social sciences/economics and business
• /medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/antibiotic resistance

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

ELIGO BIOSCIENCE

Address

29 Rue Faubourg Saint Jacques Pepin
75014 Paris
France

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 763 775